SNB-101

N/A

Report date: 2026/03/10 20:00:16

Base Information

Drug NameSNB-101

Drug Alias Name7-ethtyl-10-hydroxycamptothecin and irinotecana nanoparticle lyophilized injection of SN-387-Ethyl-10-hydroxycamptothecin and irinotecanSNB-101SN-38/irinotecan

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA topoisomerase I inhibitors

TargetsDNA topoisomerase I

Therapy Area/IndicationsSmall Cell Lung CarcinomaHead and Neck NeoplasmsOvarian Neoplasms +[7]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySerbiaSouth Korea

CombinationsYes

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSN BioScience

China Registration ClassN/A

Develop Information

Active CompaniesSN BioScience

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung CarcinomaHead and Neck NeoplasmsOvarian Neoplasms +[7]

Inactive IndicationsN/A

Other Information

ATC CodeN/A